
Marsh McLennan Agency Acquires Olympic Insurance Agency
'With their real estate expertise, dedication to innovation, and deep industry and client relationships, we look forward to the new perspectives their team will be able to offer those we serve.'
Share
Founded in 1947, Olympic primarily provides business insurance, employee benefits and personal asset protection expertise to clients in Southern California, with a specialty in working with real estate investors, property managers, and manufacturing businesses. All Olympic employees, including principals Don and Bob Barberie, will remain working out of their existing Simi Valley office.
'We have admired the team at Olympic, and Don and Bob's collaborative leadership, for many years,' said Chris Williams, CEO of MMA's West region. 'With their real estate expertise, dedication to innovation, and deep industry and client relationships, we look forward to the new perspectives their team will be able to offer those we serve.'
Don Barberie added: 'Delivering exceptional service and proactive risk management solutions has always been at the core of our mission. As we looked toward long-term growth, our priority was finding a partner who could enhance our capabilities and provide our team with the tools to better serve our clients.'
'We are thrilled to have found in MMA a firm that allows us to elevate client outcomes and support the continued professional growth of our team,' said Bob Barberie.
About Marsh McLennan Agency
Marsh McLennan Agency, a business of Marsh, is a leading provider of business insurance, employee health & benefits, retirement & wealth, and private client insurance solutions across the US and Canada. Marsh McLennan is a global leader in risk, strategy and people, advising clients in 130 countries across four businesses: Marsh, Guy Carpenter, Mercer and Oliver Wyman. With annual revenue of over $24 billion and more than 90,000 colleagues, Marsh McLennan helps build the confidence to thrive through the power of perspective. For more information, visit marshmclennan.com, follow us on LinkedIn and X.
About Marsh
Marsh, a business of Marsh McLennan (NYSE: MMC), is the world's top insurance broker and risk advisor. Marsh McLennan is a global leader in risk, strategy and people, advising clients in 130 countries across four businesses: Marsh, Guy Carpenter, Mercer and Oliver Wyman. With annual revenue of over $24 billion and more than 90,000 colleagues, Marsh McLennan helps build the confidence to thrive through the power of perspective. For more information, visit marshmclennan.com, follow us on LinkedIn and X.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 minutes ago
- Yahoo
First Eagle Investment's Strategic Moves: Spotlight on Becton Dickinson & Co
Analyzing the Latest 13F Filing for Q2 2025 First Eagle Investment (Trades, Portfolio) recently submitted its 13F filing for the second quarter of 2025, offering a glimpse into its strategic investment decisions. Established in 1864, First Eagle is a renowned independent investment management firm known for its value-oriented approach. The firm emphasizes long-term performance over short-term market fluctuations, employing rigorous bottom-up fundamental analysis to mitigate risk. First Eagle's strategy involves on-site research and direct engagement with company management to gain comprehensive insights into investment opportunities. The firm focuses on acquiring securities with intrinsic value and long-term potential that outweigh market risks. Warning! GuruFocus has detected 6 Warning Sign with META. Summary of New Buy First Eagle Investment (Trades, Portfolio) added a total of 19 stocks, among them: The most significant addition was Ferguson Enterprises Inc (NYSE:FERG), with 600,000 shares, accounting for 0.26% of the portfolio and a total value of $130.65 million. The second largest addition to the portfolio was Ciena Corp (NYSE:CIEN), consisting of 118,349 shares, representing approximately 0.02% of the portfolio, with a total value of $9,625,330. The third largest addition was FormFactor Inc (NASDAQ:FORM), with 281,444 shares, accounting for 0.02% of the portfolio and a total value of $9,684,490. Key Position Increases First Eagle Investment (Trades, Portfolio) also increased stakes in a total of 153 stocks, among them: The most notable increase was Becton Dickinson & Co (NYSE:BDX), with an additional 3,268,478 shares, bringing the total to 8,786,190 shares. This adjustment represents a significant 59.24% increase in share count, a 1.1% impact on the current portfolio, with a total value of $1,513,421,270. The second largest increase was ONEOK Inc (NYSE:OKE), with an additional 3,545,256 shares, bringing the total to 6,256,173. This adjustment represents a significant 130.78% increase in share count, with a total value of $510,691,400. Summary of Sold Out First Eagle Investment (Trades, Portfolio) completely exited 38 holdings in the second quarter of 2025, as detailed below: Brown & Brown Inc (NYSE:BRO): First Eagle Investment (Trades, Portfolio) sold all 1,921,699 shares, resulting in a -0.5% impact on the portfolio. Invesco Senior Loan ETF (BKLN): First Eagle Investment (Trades, Portfolio) liquidated all 433,094 shares, causing a -0.02% impact on the portfolio. Key Position Reduces First Eagle Investment (Trades, Portfolio) also reduced positions in 202 stocks. The most significant changes include: Reduced Philip Morris International Inc (NYSE:PM) by 1,852,263 shares, resulting in a -20.62% decrease in shares and a -0.61% impact on the portfolio. The stock traded at an average price of $171.52 during the quarter and has returned -3.46% over the past 3 months and 40.87% year-to-date. Reduced Berkshire Hathaway Inc (NYSE:BRK.A) by 263 shares, resulting in a -28.84% reduction in shares and a -0.44% impact on the portfolio. The stock traded at an average price of $762,376 during the quarter and has returned -8.41% over the past 3 months and 3.31% year-to-date. Portfolio Overview At the end of the second quarter of 2025, First Eagle Investment (Trades, Portfolio)'s portfolio included 392 stocks. The top holdings included 4.83% in Meta Platforms Inc (NASDAQ:META), 4.79% in Oracle Corp (NYSE:ORCL), 3.2% in Imperial Oil Ltd (IMO), 3.19% in Wheaton Precious Metals Corp (NYSE:WPM), and 3.17% in HCA Healthcare Inc (NYSE:HCA). The holdings are mainly concentrated in all 11 industries: Basic Materials, Healthcare, Technology, Communication Services, Consumer Defensive, Energy, Financial Services, Industrials, Real Estate, Consumer Cyclical, and Utilities. This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 minutes ago
- Yahoo
CareDx Announces Appointment of Nathan Smith as Chief Financial Officer
BRISBANE, Calif., August 06, 2025--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA), — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the appointment of Nathan Smith to the role of Chief Financial Officer. Nathan will lead key financial and accounting initiatives that are a part of the Company's long-term strategic growth plan. Nathan brings more than 14 years of experience in the molecular diagnostics industry, including senior finance leadership roles at Myriad Genetics and recent CFO positions at Blackrock Neurotech and WIN Brands. "Nathan's deep financial expertise in molecular diagnostics is a great fit for CareDx," said John Hanna, CEO of CareDx. "His track record of operational excellence and experience in supporting diagnostics companies to scale efficiently will be invaluable as we enter our next phase." In conjunction with this appointment, the Company also announced that Abhishek Jain will be retiring from his role as Chief Financial Officer. Abhishek will continue to support CareDx in a consulting capacity to ensure a seamless transition. "On behalf of the Board and the entire CareDx team, I want to express my sincere gratitude to Abhishek for his outstanding leadership as CFO," said John Hanna. "Abhishek's disciplined financial management, stewardship through our CEO transition, and dedication to strengthening our finance function have positioned CareDx for continued success. We wish him all the best." About CareDx CareDx, Inc., headquartered in Brisbane, California, is a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. For more information, visit Forward Looking Statements This press release includes forward-looking statements related to CareDx, Inc. These forward-looking statements are based upon information that is currently available to CareDx and its current expectations, speak only as of the date hereof, and are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including general economic and market factors and other risks discussed in CareDx's filings with the SEC, including, but not limited to, the Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed by CareDx with the SEC on February 28, 2025, the Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 filed by CareDx with the SEC on April 30, 2025, and other reports that CareDx has filed with the SEC. Any of these may cause CareDx's actual results, performance, or achievements to differ materially and adversely from those anticipated or implied by CareDx's forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements. CareDx expressly disclaims any obligation, except as required by law, or undertaking to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise. View source version on Contacts CareDx Media Contacts Natasha Moshirian Wagnernwagner@ Investor RelationsCaroline Cornerinvestor@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Yahoo
2 minutes ago
- Yahoo
Fortinet signals strength in SASE and AI, but market looks for more
-- Shares of Fortinet Inc (NASDAQ:FTNT) edged down 3.7% in after-hours trading Wednesday, as investors weighed strong second-quarter earnings against continued macroeconomic caution and modest top-line momentum. The pullback came despite the company raising its full-year billings outlook and maintaining healthy margin guidance. The cybersecurity firm reported adjusted earnings per share of $0.64 for the quarter ended June 30, exceeding Wall Street expectations of $0.59. Revenue totaled $1.63 billion, in line with consensus estimates, reflecting stable uptake of both products and high-margin services. Billings outperformed guidance, and Fortinet now expects full-year billings between $7.325 billion and $7.475 billion, a bullish signal for forward revenue growth. It guided for gross and operating margins as high as 81% and 33.5%, respectively, demonstrating continued cost discipline and scalability. 'Our strong second quarter performance and consistent track record of growth are a direct result of our continued innovation and customer-first strategy,' said CEO Ken Xie. 'We are the industry leader in network security... underscores the strength of our AI-driven security approach and the strategic advantage of our unified FortiOS operating system.' Fortinet has continued to strengthen its position in converged networking and security, with recent gains in Secure Access Service Edge (SASE) and Security Operations. The company's recognition in five distinct Gartner (NYSE:IT) Magic Quadrant™ reports and expansion of the FortiCloud platform, with new services such as FortiIdentity and FortiConnect, highlight its commitment to innovation-driven differentiation. Despite a premium valuation and shares underperforming in recent weeks, investor sentiment will likely hinge on Fortinet's ability to accelerate revenue growth amid heightened competition. With firewall upgrades expected to ramp and AI innovation remaining a focus, Fortinet remains well-positioned but must execute against elevated expectations. Related articles Fortinet signals strength in SASE and AI, but market looks for more If Powell goes, does Fed trust go with him? 7 Undervalued Stocks on the Rise With 50%+ Upside Potential Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data